— Know what they know.
Not Investment Advice

VCYT NASDAQ

Veracyte, Inc.
1W: +10.1% 1M: +6.1% 3M: -13.4% YTD: +13.7% 1Y: +35.2% 3Y: +131.8% 5Y: +6.8%
$50.28
+2.08 (+4.32%)
After Hours: $50.75 (+0.47, +0.94%)
Weekly Expected Move ±6.8%
$41 $45 $48 $51 $54
NASDAQ · Healthcare · Medical - Diagnostics & Research · Tech Score Strong Buy · Power 74 · $3.9B mcap · 80M float · 1.69% daily turnover · Short 75% of daily vol
Credit Risk of going bust: lower than 72% of companies Debt: 1.0% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.07 (down 99.9%), Veracyte, Inc. would be worth roughly what it owes.
Total debt $40.1M against a stock market value of $3.87B.
Distance to default 8.00 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $20.1M (short-term plus half of long-term), stock volatility 64.2%; Altman Z'' 16.92. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
64.5 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: 10.7%  ·  5Y Avg: -1.4%
Cost Advantage
60
Intangibles
81
Switching Cost
64
Network Effect
68
Scale
40
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. VCYT has a Narrow competitive edge (64.5/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Intangible Assets. ROIC of 10.7% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$44
Low
$56
Avg Target
$69
High
Based on 6 analysts since Jul 30, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 15Hold: 6Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$56.17
Analysts6
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-09-09 UBS — $52 $65 +13 +53.1% $42.45
2026-08-04 Morgan Stanley — $47 $44 -3 -1.1% $44.49
2026-08-04 Stephens — Initiated $55 — +22.6% $44.85
2026-08-04 Piper Sandler — $66 $54 -12 +20.4% $44.85
2026-08-03 Canaccord Genuity Kyle Mikson $60 $50 -10 +7.9% $46.32
2026-07-31 Needham Mike Matson $57 $69 +12 +15.4% $59.78
2026-07-15 Piper Sandler David Westenberg Initiated $66 — +16.6% $56.62
2026-07-14 Canaccord Genuity — $42 $60 +18 +4.4% $57.48
2026-07-09 Morgan Stanley — $37 $47 +10 -16.3% $56.12
2026-06-29 Guggenheim Subbu Nambi $50 $65 +15 +7.5% $60.49
2026-06-01 Needham Mike Matson $44 $57 +13 +17.8% $48.38
2026-05-06 UBS — $48 $52 +4 +31.8% $39.44
2026-05-06 Canaccord Genuity Kyle Mikson $43 $42 -1 +27.4% $32.97
2026-03-05 Morgan Stanley Kallum Titchmarsh $48 $37 -11 +6.7% $34.68
2026-01-05 Guggenheim Subbu Nambi Initiated $50 — +16.4% $42.95
2025-12-01 Morgan Stanley — $28 $48 +20 +3.5% $46.39
2025-11-05 UBS Lu Li Initiated $48 — +10.0% $43.64
2025-11-05 Canaccord Genuity Kyle Mikson $40 $43 +3 +19.0% $36.12
2025-10-20 Canaccord Genuity Kyle Mikson Initiated $40 — +11.6% $35.83
2025-08-08 Morgan Stanley Tejas Savant $26 $28 +2 +2.3% $27.37
2024-11-07 Needham Mike Matson $26 $44 +18 +22.7% $35.85
2024-08-12 Morgan Stanley Tejas Savant $23 $26 +3 -11.6% $29.41
2022-05-04 Morgan Stanley — Initiated $23 — +9.5% $21.00
2022-05-04 Needham — Initiated $26 — +21.2% $21.46

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
Oct 27, 2026
DCF
4
ROE
3
ROA
5
D/E
4
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. VCYT receives an overall rating of B+. Strongest factors: DCF (4/5), ROA (5/5), D/E (4/5). Areas of concern: P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-10-12 B B+
2026-10-01 A- B
2026-08-14 B+ A-
2026-07-31 A- B+
2026-07-01 B+ A-
2026-06-01 A- B+
2026-05-11 B+ A-
2026-05-06 A- B+
2026-05-05 B+ A-
2026-04-28 B B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 79 Grade A+
Profitability
58
Balance Sheet
86
Earnings Quality
81
Growth
70
Value
41
Momentum
95
Safety
100
Cash Flow
96
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. VCYT scores highest in Safety (100/100) and lowest in Value (41/100). An overall grade of A+ places VCYT among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
30.31
Safe Zone
Piotroski F-Score
8/9
✓ ✓ ✓ ✓ ✓ ✓ ✗ ✓ ✓
Beneish M-Score
-2.63
Unlikely Manipulator
Ohlson O-Score
-13.84
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA+
Score: 93.5/100
Trend: Deteriorating
Earnings Quality
100/100
OCF/NI: 1.56x
Accruals: -4.5%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. VCYT scores 30.31, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. VCYT scores 8/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. VCYT's score of -2.63 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. VCYT's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. VCYT receives an estimated rating of AA+ (score: 93.5/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). VCYT's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
35.85x
PEG
0.12x
P/S
7.38x
P/B
2.96x
P/FCF
29.19x
P/OCF
27.07x
EV/EBITDA
33.78x
EV/Revenue
7.80x
EV/EBIT
40.24x
EV/FCF
26.50x
Earnings Yield
2.37%
FCF Yield
3.43%
Shareholder Yield
0.09%
Graham Number
$23.00
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 35.8x earnings, VCYT commands a growth premium. Graham's intrinsic value formula yields $23.00 per share, 110% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.051
NI / EBT
×
Interest Burden
1.000
EBT / EBIT
×
EBIT Margin
0.194
EBIT / Rev
×
Asset Turnover
0.397
Rev / Assets
×
Equity Multiplier
1.085
Assets / Equity
=
ROE
8.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. VCYT's ROE of 8.8% is driven by Asset Turnover (0.397), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.05 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$53.60
Price/Value
1.10x
Margin of Safety
-9.56%
Premium
9.56%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with VCYT's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. VCYT trades at a 10% premium to its adjusted intrinsic value of $53.60, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 35.8x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$50.28
Median 1Y
$44.15
5th Pctile
$15.40
95th Pctile
$128.32
Ann. Volatility
66.0%
Analyst Target
$56.17
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Marc Stapley
Chief Executive Officer
$700,000 $5,890,877 $7,421,877
John Leite Global
Chief Commercial Officer
$510,300 $2,356,325 $3,202,810
Rebecca Chambers Financial
ancial Officer
$550,000 $1,963,604 $2,875,554
Annie McGuire Counsel
Counsel and Head of Market Access
$500,000 $1,963,604 $2,793,104
Phillip Febbo Scientific
ntific Officer and Chief Medical Officer
$561,000 $1,570,883 $2,500,972

CEO Pay Ratio

27:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $7,421,877
Avg Employee Cost (SGA/emp): $279,403
Employees: 755

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
755
-8.4% YoY
Revenue / Employee
$684,960
Rev: $517,145,000
Profit / Employee
$87,885
NI: $66,353,000
SGA / Employee
$279,403
Avg labor cost proxy
R&D / Employee
$93,793
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -9.6% -10.0% -4.7% -4.8% -4.0% -3.4% -2.8% -2.7% -4.8% -7.0% -6.2% -4.9% -0.8% 2.2% 2.9% 2.2% 2.5% 5.3% 6.9% 8.8% 8.77%
ROA -8.9% -9.2% -4.4% -4.5% -3.7% -3.1% -2.6% -2.5% -4.4% -6.6% -5.8% -4.5% -0.8% 2.0% 2.6% 2.0% 2.3% 4.9% 6.4% 8.1% 8.09%
ROIC -6.4% -6.9% -4.3% -4.7% -4.2% -3.6% -3.1% -2.9% -5.1% -8.1% -6.8% -5.8% -2.0% 1.6% 2.3% 1.3% 2.6% 4.8% 6.9% 10.7% 10.66%
ROCE -6.9% -7.2% -4.5% -4.7% -4.1% -3.3% -2.7% -2.6% -4.6% -7.3% -6.3% -4.9% -0.8% 2.0% 2.3% 1.8% 1.9% 4.6% 6.6% 7.7% 7.65%
Gross Margin 64.1% 66.0% 65.0% 65.6% 65.6% 66.6% 68.2% 61.8% 69.4% 70.1% 64.5% 68.1% 68.2% 66.4% 69.5% 69.0% 69.2% 74.4% 72.3% 72.2% 72.21%
Operating Margin -27.6% -18.3% -22.5% -14.7% -12.8% -6.7% -12.7% -8.9% -35.2% -36.2% -4.8% 4.0% 10.4% 3.5% 2.5% -4.0% 17.4% 18.4% 17.1% 15.3% 15.29%
Net Margin -23.4% -15.6% -21.3% -13.1% -11.5% -4.8% -9.8% -9.3% -32.9% -28.8% -1.9% 5.0% 13.1% 4.3% 6.2% -0.8% 14.5% 29.3% 20.6% 17.0% 16.96%
EBITDA Margin -15.4% -7.2% -11.6% -4.2% -2.2% 3.9% -1.7% -1.6% -24.9% -24.6% 2.0% 11.4% 19.6% 8.2% 5.7% 5.2% 18.3% 32.7% 25.5% 16.2% 16.15%
FCF Margin -23.2% -16.9% -2.6% -3.7% -0.5% -0.3% 2.3% 7.0% 8.5% 9.5% 7.0% 10.0% 13.3% 14.3% 16.9% 17.5% 19.8% 24.4% 28.6% 29.4% 29.45%
OCF Margin -20.2% -14.4% 0.0% -0.8% 2.2% 2.5% 4.6% 9.5% 11.2% 12.2% 10.0% 12.6% 15.5% 16.8% 19.3% 19.5% 21.9% 26.4% 30.7% 31.7% 31.75%
ROE 3Y Avg snapshot only 1.88%
ROE 5Y Avg snapshot only -0.33%
ROA 3Y Avg snapshot only 1.76%
ROIC 3Y Avg snapshot only 1.88%
ROIC Economic snapshot only 7.10%
Cash ROA snapshot only 12.00%
Cash ROIC snapshot only 18.91%
CROIC snapshot only 17.54%
NOPAT Margin snapshot only 17.90%
Pretax Margin snapshot only 19.39%
R&D / Revenue snapshot only 16.62%
SGA / Revenue snapshot only 35.88%
SBC / Revenue snapshot only 8.63%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -44.33 -38.75 -40.78 -29.24 -27.51 -46.62 -53.31 -63.52 -32.54 -27.03 -24.30 -30.94 -288.19 131.09 71.82 82.01 90.24 51.64 29.76 42.18 35.846
P/S Ratio 17.35 13.34 7.84 5.30 4.19 5.75 5.17 5.62 4.74 5.57 4.41 4.18 6.28 7.10 5.12 4.51 5.53 6.63 4.83 8.59 7.385
P/B Ratio 2.93 2.67 1.81 1.34 1.13 1.59 1.49 1.70 1.54 1.93 1.48 1.48 2.27 2.69 1.99 1.77 2.18 2.62 1.95 3.48 2.961
P/FCF -74.94 -79.14 -299.13 -145.17 -928.57 -1680.89 225.23 80.19 55.91 58.70 62.93 41.67 47.29 49.59 30.26 25.72 27.86 27.17 16.92 29.19 29.187
P/OCF — — 28879.44 — 190.72 226.20 113.07 59.04 42.32 45.48 44.26 33.22 40.39 42.14 26.54 23.11 25.27 25.14 15.76 27.07 27.072
EV/EBITDA -49.17 -44.80 -68.36 -50.92 -59.47 -162.92 -478.45 -1235.94 -64.86 -36.58 -31.73 -46.19 177.28 61.64 41.05 41.36 51.15 36.63 19.78 33.78 33.782
EV/Revenue 16.57 12.62 7.26 4.75 3.65 5.19 4.64 5.08 4.19 5.01 3.89 3.65 5.68 6.56 4.61 3.94 4.87 5.90 4.10 7.80 7.802
EV/EBIT -39.60 -34.02 -36.23 -25.19 -23.52 -42.51 -48.32 -58.37 -28.99 -23.60 -20.25 -25.77 -243.83 121.89 74.15 83.23 97.38 49.29 24.46 40.24 40.242
EV/FCF -71.58 -74.86 -277.01 -130.23 -808.79 -1519.02 202.27 72.53 49.42 52.75 55.52 36.31 42.79 45.85 27.24 22.51 24.54 24.21 14.34 26.50 26.497
Earnings Yield -2.3% -2.6% -2.5% -3.4% -3.6% -2.1% -1.9% -1.6% -3.1% -3.7% -4.1% -3.2% -0.3% 0.8% 1.4% 1.2% 1.1% 1.9% 3.4% 2.4% 2.37%
FCF Yield -1.3% -1.3% -0.3% -0.7% -0.1% -0.1% 0.4% 1.2% 1.8% 1.7% 1.6% 2.4% 2.1% 2.0% 3.3% 3.9% 3.6% 3.7% 5.9% 3.4% 3.43%
PEG Ratio snapshot only 0.115
Price/Tangible Book snapshot only 8.967
EV/OCF snapshot only 24.577
EV/Gross Profit snapshot only 10.822
Acquirers Multiple snapshot only 45.801
Shareholder Yield snapshot only 0.09%
Graham Number snapshot only $23.00
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 4.58 3.79 3.81 3.96 4.09 3.97 4.49 4.46 4.74 4.66 5.00 4.44 5.08 4.73 5.10 5.43 6.23 8.15 9.31 9.16 9.162
Quick Ratio 4.39 3.61 3.62 3.71 3.85 3.74 4.25 4.26 4.46 4.40 4.69 4.17 4.79 4.46 4.78 5.10 5.94 7.81 8.92 8.80 8.801
Debt/Equity 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.04 0.04 0.04 0.03 0.03 0.03 0.03 0.029
Net Debt/Equity -0.13 -0.14 -0.13 -0.14 -0.15 -0.15 -0.15 -0.16 -0.18 -0.20 -0.17 -0.19 -0.22 -0.20 -0.20 -0.22 -0.26 -0.29 -0.30 -0.32 -0.321
Debt/Assets 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.04 0.04 0.04 0.03 0.03 0.03 0.03 0.027
Debt/EBITDA -0.30 -0.30 -0.69 -0.70 -0.96 -1.56 -4.56 -11.00 -0.62 -0.26 -0.30 -0.66 1.44 1.07 0.97 1.11 0.86 0.48 0.35 0.31 0.309
Net Debt/EBITDA 2.31 2.56 5.46 5.84 8.81 17.36 54.32 130.48 8.52 4.13 4.24 6.82 -18.66 -5.03 -4.55 -5.91 -6.92 -4.48 -3.56 -3.43 -3.430
Interest Coverage -338.29 -337.79 -201.61 -197.86 -172.06 -183.91 -209.17 -376.42 -2915.53 -5471.29 -10309.43 -11306.00 -2477.75 12001.00 14409.00 22706.00 — — — — —
Equity Multiplier 1.07 1.08 1.08 1.08 1.07 1.08 1.07 1.07 1.07 1.07 1.07 1.09 1.08 1.11 1.10 1.10 1.09 1.07 1.07 1.07 1.071
Cash Ratio snapshot only 7.735
Cash to Debt snapshot only 12.098
FCF to Debt snapshot only 4.125
Defensive Interval snapshot only 636.4 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.23 0.27 0.23 0.25 0.25 0.25 0.27 0.29 0.30 0.32 0.32 0.33 0.35 0.37 0.37 0.37 0.37 0.38 0.39 0.40 0.397
Inventory Turnover 8.78 9.37 9.18 8.77 8.27 7.96 8.11 8.68 7.76 7.74 7.96 8.30 7.56 7.79 6.96 6.87 7.66 7.18 6.81 6.58 6.578
Receivables Turnover 6.45 7.33 7.12 7.42 7.06 6.94 7.07 7.94 8.65 8.56 8.15 8.62 9.66 10.26 9.23 9.48 10.25 11.34 10.43 10.70 10.704
Payables Turnover 9.55 9.61 9.31 9.92 8.75 8.37 7.73 9.78 9.74 9.47 9.05 10.24 12.35 13.68 10.64 12.93 20.53 22.97 13.74 16.11 16.106
DSO 57 50 51 49 52 53 52 46 42 43 45 42 38 36 40 39 36 32 35 34 34.1 days
DIO 42 39 40 42 44 46 45 42 47 47 46 44 48 47 52 53 48 51 54 55 55.5 days
DPO 38 38 39 37 42 44 47 37 37 39 40 36 30 27 34 28 18 16 27 23 22.7 days
Cash Conversion Cycle 60 51 52 54 54 55 49 51 52 51 50 51 57 56 58 63 65 67 62 67 66.9 days
Fixed Asset Turnover snapshot only 9.841
Operating Cycle snapshot only 89.6 days
Cash Velocity snapshot only 1.158
Capital Intensity snapshot only 2.645
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 65.7% 86.8% 1.0% 70.4% 51.9% 35.1% 24.2% 22.5% 21.0% 21.8% 20.7% 21.6% 23.9% 23.5% 23.4% 19.9% 16.4% 16.0% 16.9% 17.3% 17.28%
Net Income -1.1% -1.2% 26.0% 22.9% 40.8% 51.6% 37.3% 40.3% -15.5% -1.0% -1.3% -86.0% 81.4% 1.3% 1.5% 1.5% 4.3% 1.7% 1.7% 3.3% 3.35%
EPS -67.5% -76.7% 34.2% 27.4% 42.4% 52.1% 38.1% 41.1% -13.7% -99.9% -1.2% -74.7% 82.8% 1.3% 1.5% 1.5% 4.2% 1.7% 1.6% 3.2% 3.22%
FCF -2.3% -1.9% 86.4% 74.8% 97.0% 97.3% 2.1% 3.3% 23.7% 34.8% 2.7% 74.3% 94.2% 86.2% 2.0% 1.1% 73.9% 97.6% 97.3% 97.0% 97.05%
EBITDA -1.3% -1.3% 55.7% 55.0% 72.3% 84.7% 88.6% 94.6% -27.2% -4.2% -14.2% -22.3% 1.6% 2.0% 2.1% 2.4% 2.5% 75.6% 1.2% 1.8% 1.84%
Op. Income -1.2% -1.3% 24.6% 15.4% 38.2% 49.8% 29.8% 38.8% -16.1% -1.1% -1.2% -100.0% 57.7% 1.2% 1.3% 1.2% 2.1% 1.9% 1.8% 5.9% 5.92%
OCF Growth snapshot only 90.88%
Asset Growth snapshot only 10.58%
Equity Growth snapshot only 13.71%
Debt Growth snapshot only -20.81%
Shares Change snapshot only 2.90%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 29.6% 33.6% 35.2% 35.1% 34.6% 35.1% 36.6% 42.9% 44.9% 45.4% 45.0% 36.4% 31.6% 26.6% 22.7% 21.3% 20.4% 20.4% 20.3% 19.6% 19.58%
Revenue 5Y 25.1% 27.5% 29.8% 30.2% 32.1% 32.7% 32.7% 32.7% 31.9% 31.4% 29.9% 29.7% 29.6% 29.9% 30.6% 33.6% 34.5% 34.5% 34.5% 29.0% 28.97%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y 32.2% 35.0% 34.5% 32.9% 31.8% 32.5% 36.3% 43.1% 46.6% 47.4% 45.3% 36.8% 32.5% 27.1% 24.1% 23.2% 22.2% 23.3% 23.1% 23.5% 23.50%
Gross Profit 5Y 28.2% 29.6% 31.2% 30.9% 33.6% 34.8% 35.2% 34.5% 33.5% 32.8% 29.8% 29.5% 28.8% 28.9% 31.0% 34.8% 36.2% 36.9% 36.5% 30.7% 30.74%
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — 1.8% 93.0% 92.98%
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — 10.0% — 1.6% 1.6% 1.3% 78.7% 78.68%
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y 1.2% 1.1% 1.1% 65.5% 62.9% 61.4% 63.0% 65.4% 35.3% 34.6% 5.4% 6.3% 2.4% 3.1% 3.9% 5.5% 6.7% 6.7% 7.5% 8.6% 8.58%
Assets 5Y 76.3% 63.7% 66.2% 66.9% 68.2% 71.2% 74.7% 77.7% 56.7% 56.0% 57.6% 37.4% 37.4% 36.4% 37.6% 39.2% 24.7% 25.2% 7.0% 7.7% 7.66%
Equity 3Y 1.4% 1.4% 1.3% 68.0% 65.5% 65.0% 67.4% 68.5% 35.6% 35.3% 4.7% 5.3% 2.0% 2.4% 3.3% 4.7% 6.3% 6.8% 7.5% 8.6% 8.64%
Book Value 3Y 97.6% 99.0% 95.6% 44.7% 45.4% 45.3% 47.9% 49.1% 23.4% 25.3% -0.9% 0.6% -1.9% -1.6% -0.7% 0.9% 2.6% 2.4% 3.3% 4.2% 4.17%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.83 0.76 0.72 0.77 0.81 0.84 0.84 0.88 0.90 0.91 0.91 0.95 0.97 0.99 1.00 1.00 1.00 1.00 1.00 1.00 0.999
Earnings Stability 0.23 0.30 0.34 0.47 0.36 0.27 0.15 0.16 0.38 0.56 0.42 0.29 0.00 0.02 0.17 0.31 0.57 0.53 0.69 0.72 0.722
Margin Stability 0.94 0.95 0.97 0.97 0.96 0.95 0.96 0.97 0.97 0.98 0.99 0.98 0.98 0.98 0.99 0.98 0.97 0.97 0.97 0.96 0.964
Rev. Growth Consistency 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.90 0.91 0.84 0.50 0.85 0.84 0.94 0.50 0.50 0.50 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.500
Earnings Smoothness — — — — — — — — — — — — — — — — — 0.07 0.09 0.00 0.000
ROE Trend -0.01 -0.00 0.04 0.06 0.03 0.04 0.03 0.03 0.01 -0.02 -0.02 -0.01 0.04 0.07 0.07 0.06 0.05 0.08 0.08 0.10 0.096
Gross Margin Trend -0.01 -0.01 -0.01 -0.01 0.00 0.00 0.01 -0.01 0.00 0.01 0.00 0.03 0.02 0.00 0.02 0.02 0.01 0.03 0.04 0.04 0.040
FCF Margin Trend -0.14 -0.09 0.21 0.16 0.17 0.13 0.23 0.21 0.20 0.18 0.07 0.08 0.09 0.10 0.12 0.09 0.09 0.12 0.17 0.16 0.157
Sustainable Growth Rate — — — — — — — — — — — — — 2.2% 2.9% 2.2% 2.5% 5.3% 6.9% 8.8% 8.77%
Internal Growth Rate — — — — — — — — — — — — — 2.0% 2.7% 2.1% 2.3% 5.2% 6.8% 8.8% 8.80%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.52 0.42 -0.00 0.04 -0.14 -0.21 -0.47 -1.08 -0.77 -0.59 -0.55 -0.93 -7.13 3.11 2.71 3.55 3.57 2.05 1.89 1.56 1.558
FCF/OCF 1.14 1.17 -96.54 4.49 -0.21 -0.13 0.50 0.74 0.76 0.77 0.70 0.80 0.85 0.85 0.88 0.90 0.91 0.93 0.93 0.93 0.928
FCF/Net Income snapshot only 1.445
OCF/EBITDA snapshot only 1.375
CapEx/Revenue 2.9% 2.4% 2.6% 2.8% 2.7% 2.9% 2.3% 2.5% 2.7% 2.8% 3.0% 2.6% 2.3% 2.5% 2.4% 2.0% 2.0% 2.0% 2.1% 2.3% 2.30%
CapEx/Depreciation snapshot only 0.620
Accruals Ratio -0.04 -0.05 -0.04 -0.04 -0.04 -0.04 -0.04 -0.05 -0.08 -0.10 -0.09 -0.09 -0.06 -0.04 -0.04 -0.05 -0.06 -0.05 -0.06 -0.05 -0.045
Sloan Accruals snapshot only 0.108
Cash Flow Adequacy snapshot only 13.800
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio — — — — — — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio — — — — — — — — — — — — — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 3.8% 3.75%
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.09%
Net Buyback Yield -18.3% -20.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -0.2% -0.3% -0.5% -0.3% -0.33%
Total Shareholder Return -18.3% -20.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -0.2% -0.3% -0.5% -0.3% -0.33%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.93 0.93 0.95 0.96 0.98 1.00 1.00 1.01 1.01 0.97 0.97 0.99 1.13 0.94 0.94 0.91 0.98 0.97 0.97 1.05 1.051
Interest Burden (EBT/EBIT) 1.00 1.00 1.00 1.01 1.01 1.01 1.00 1.00 1.00 1.00 0.98 0.97 0.82 1.07 1.22 1.28 1.25 1.10 1.00 1.00 1.000
EBIT Margin -0.42 -0.37 -0.20 -0.19 -0.16 -0.12 -0.10 -0.09 -0.14 -0.21 -0.19 -0.14 -0.02 0.05 0.06 0.05 0.05 0.12 0.17 0.19 0.194
Asset Turnover 0.23 0.27 0.23 0.25 0.25 0.25 0.27 0.29 0.30 0.32 0.32 0.33 0.35 0.37 0.37 0.37 0.37 0.38 0.39 0.40 0.397
Equity Multiplier 1.07 1.08 1.07 1.07 1.07 1.08 1.08 1.07 1.07 1.07 1.07 1.08 1.08 1.09 1.09 1.10 1.09 1.09 1.08 1.08 1.085
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-1.05 $-1.06 $-0.68 $-0.68 $-0.60 $-0.51 $-0.42 $-0.40 $-0.69 $-1.02 $-0.91 $-0.70 $-0.12 $0.30 $0.41 $0.33 $0.38 $0.82 $1.08 $1.39 $1.39
Book Value/Share $15.87 $15.43 $15.24 $14.89 $14.63 $14.97 $14.98 $14.94 $14.48 $14.28 $14.96 $14.68 $14.99 $14.72 $14.93 $15.28 $15.78 $16.09 $16.53 $16.89 $17.43
Tangible Book/Share $2.63 $2.62 $2.59 $2.65 $2.72 $2.85 $2.93 $3.02 $3.26 $3.45 $3.32 $3.47 $3.89 $4.10 $4.27 $4.41 $4.99 $5.57 $6.04 $6.55 $6.55
Revenue/Share $2.68 $3.09 $3.52 $3.75 $3.96 $4.13 $4.31 $4.53 $4.71 $4.94 $5.02 $5.18 $5.42 $5.58 $5.79 $6.00 $6.21 $6.35 $6.66 $6.83 $7.05
FCF/Share $-0.62 $-0.52 $-0.09 $-0.14 $-0.02 $-0.01 $0.10 $0.32 $0.40 $0.47 $0.35 $0.52 $0.72 $0.80 $0.98 $1.05 $1.23 $1.55 $1.90 $2.01 $2.08
OCF/Share $-0.54 $-0.44 $0.00 $-0.03 $0.09 $0.10 $0.20 $0.43 $0.53 $0.60 $0.50 $0.65 $0.84 $0.94 $1.12 $1.17 $1.36 $1.67 $2.04 $2.17 $2.24
Cash/Share $2.35 $2.49 $2.30 $2.29 $2.37 $2.49 $2.46 $2.64 $2.78 $2.96 $2.80 $3.06 $3.49 $3.62 $3.59 $4.01 $4.60 $5.07 $5.40 $5.90 $6.09
EBITDA/Share $-0.90 $-0.87 $-0.37 $-0.35 $-0.24 $-0.13 $-0.04 $-0.02 $-0.30 $-0.68 $-0.62 $-0.41 $0.17 $0.59 $0.65 $0.57 $0.59 $1.02 $1.38 $1.58 $1.58
Debt/Share $0.27 $0.27 $0.26 $0.25 $0.23 $0.20 $0.19 $0.21 $0.19 $0.17 $0.19 $0.27 $0.25 $0.63 $0.63 $0.63 $0.51 $0.49 $0.48 $0.49 $0.49
Net Debt/Share $-2.08 $-2.23 $-2.04 $-2.05 $-2.14 $-2.29 $-2.27 $-2.43 $-2.59 $-2.79 $-2.61 $-2.79 $-3.24 $-2.99 $-2.96 $-3.38 $-4.09 $-4.59 $-4.92 $-5.41 $-5.41
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 30.306
Altman Z-Prime snapshot only 53.803
Piotroski F-Score 2 3 5 4 6 7 7 6 6 6 5 4 5 6 7 7 7 8 8 8 8
Beneish M-Score 0.35 0.42 -1.82 -2.25 -2.66 -2.67 -2.59 -2.61 -2.85 -3.06 -2.81 -2.72 -2.49 -2.47 -2.60 -2.69 -2.76 -2.73 -2.74 -2.63 -2.626
Ohlson O-Score snapshot only -13.844
ROIC (Greenblatt) snapshot only 19.14%
Net-Net WC snapshot only $5.80
EVA snapshot only $6260448.52
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only AA+
Credit Score 58.83 59.35 63.87 61.80 66.05 67.57 69.88 70.80 71.02 71.10 71.37 71.71 69.40 94.99 96.54 94.93 93.38 93.64 93.08 93.50 93.498
Credit Grade snapshot only 2
Credit Trend snapshot only -1.428
Implied Spread (bps) snapshot only 65.000
Industry Credit Rank snapshot only 89
Sector Credit Rank snapshot only 90

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms